Works matching IS 14741776 AND DT 2009 AND VI 8 AND IP 10

Results: 23

Beyond debacle and debate: developing solutions in drug safety.

Published in:

2009

By:

Ray, Amrit

Publication type:

review

New approaches to drug safety: a pharmacovigilance tool kit.

Published in:

2009

By:

Wise, Lesley;
Parkinson, John;
Raine, June;
Breckenridge, Alasdair

Publication type:

review

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases.

Published in:

2009

By:

Imig, John D.;
Hammock, Bruce D.

Publication type:

journal article

In Brief.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 774, doi. 10.1038/nrd3007
Publication type:: Article

Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 783, doi. 10.1038/nrd2959

By:

Brunden, Kurt R.;
Trojanowski, John Q.;
Lee, Virginia M.-Y.

Publication type:

Article

Tumour-initiating cells: challenges and opportunities for anticancer drug discovery.

Published in:

2009

By:

Zhou, Bin-Bing S.;
Zhang, Haiying;
Damelin, Marc;
Geles, Kenneth G.;
Grindley, Justin C.;
Dirks, Peter B.

Publication type:

journal article

Stem cells: Tailored drug screening.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 774, doi. 10.1038/nrd3023

By:

Flight, Monica Hoyos

Publication type:

Article

Neurodegenerative disorders: A biomarker and a target for progressive MS.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 771, doi. 10.1038/nrd3006

By:

Kingwell, Katie

Publication type:

Article

Autoimmune disease: SIRT1 keeps escapees quiet.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 772, doi. 10.1038/nrd3022

By:

Ryan, Gemma

Publication type:

Article

Psoriasis market.

Published in:

2009

By:

Melnikova, Irena

Publication type:

journal article

Dronedarone.

Published in:

2009

By:

Page, Richard L.;
Hamad, Bashar;
Kirkpatrick, Peter

Publication type:

journal article

Neuroscience R&D.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 825, doi. 10.1038/nrd3001
Publication type:: Article

Market watch: Upcoming market catalysts in Q4 2009.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 763, doi. 10.1038/nrd3004

By:

Jatkoe, Ly

Publication type:

Article

Fibrotic disease: A pair of novel targets.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 773, doi. 10.1038/nrd3005

By:

Harrison, Charlotte

Publication type:

Article

Santhera licenses novel dyskinesia therapy to Biovail.

Published in:: 2009
Publication type:: journal article

Drug metabolism: Microbial metabolite predicts human metabolism.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 772, doi. 10.1038/nrd3008

By:

Crunkhorn, Sarah

Publication type:

Article

Morgan Sheng.

Published in:: 2009
Publication type:: Interview

Late-stage osteoporosis drugs illustrate challenges in the field.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 757, doi. 10.1038/nrd3015

By:

Opar, Alisa

Publication type:

Article

Lessons from the lung for targeted anticancer drugs.

Published in:

2009

By:

Hughes, Bethan

Publication type:

journal article

Patent watch.

Published in:

Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 764, doi. 10.1038/nrd3017

By:

Harrison, Charlotte

Publication type:

Article

Mixed results for novel CD20-targeted antibody.

Published in:: 2009
Publication type:: journal article

In this issue.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 753, doi. 10.1038/nrd3020
Publication type:: Article

The evolution of trial registration.

Published in:: Nature Reviews Drug Discovery, 2009, v. 8, n. 10, p. 755, doi. 10.1038/nrd3021
Publication type:: Article